(Q33531333)

27 July 2017

title

Synthetic constrained peptide selectively binds and antagonizes death receptor 5. (English)

1 reference

27 July 2017

Eva Szegezdi

0 references

Afshin Samali

0 references

Johanna Vrielink

1 reference

27 July 2017

Mariette S Heins

1 reference

27 July 2017

Rita Setroikromo

1 reference

27 July 2017

Margaret M Mullally

1 reference

27 July 2017

Wim J Quax

1 reference

27 July 2017

language of work or name

English

0 references

publication date

12 February 2010

1 reference

27 July 2017

1 reference

27 July 2017

volume

277

1 reference

27 July 2017

1 reference

27 July 2017

page(s)

1653-1665

1 reference

Safety and antitumor activity of recombinant soluble Apo2 ligand

27 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-4658.2010.07590.X

Neurodegeneration in autoimmune demyelination: recent mechanistic insights reveal novel therapeutic targets

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-4658.2010.07590.X

Blockade of the tumor necrosis factor-related apoptosis inducing ligand death receptor DR5 prevents beta-amyloid neurotoxicity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-4658.2010.07590.X

The receptor for the cytotoxic ligand TRAIL

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-4658.2010.07590.X

An Antagonist Decoy Receptor and a Death Domain-Containing Receptor for TRAIL

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-4658.2010.07590.X

Control of TRAIL-Induced Apoptosis by a Family of Signaling and Decoy Receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-4658.2010.07590.X

TRAIL-R2: a novel apoptosis-mediating receptor for TRAIL.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-4658.2010.07590.X

Biochemical pathways of caspase activation during apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-4658.2010.07590.X

Apo2L/TRAIL and its death and decoy receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-4658.2010.07590.X

TRUNDD, a new member of the TRAIL receptor family that antagonizes TRAIL signalling

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-4658.2010.07590.X

Osteoprotegerin is a receptor for the cytotoxic ligand TRAIL.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-4658.2010.07590.X

Triggering cell death: the crystal structure of Apo2L/TRAIL in a complex with death receptor 5

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-4658.2010.07590.X

Structure of the TRAIL-DR5 complex reveals mechanisms conferring specificity in apoptotic initiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-4658.2010.07590.X

Crystal structure of TRAIL-DR5 complex identifies a critical role of the unique frame insertion in conferring recognition specificity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-4658.2010.07590.X

Identification and characterization of a ligand-independent oligomerization domain in the extracellular region of the CD95 death receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-4658.2010.07590.X

A domain in TNF receptors that mediates ligand-independent receptor assembly and signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-4658.2010.07590.X

Fas preassociation required for apoptosis signaling and dominant inhibition by pathogenic mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-4658.2010.07590.X

The C-terminal tails of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) and Fas receptors have opposing functions in Fas-associated death domain (FADD) recruitment and can regulate agonist-specific mechanisms of receptor activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-4658.2010.07590.X

A novel anti-human DR5 monoclonal antibody with tumoricidal activity induces caspase-dependent and caspase-independent cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-4658.2010.07590.X

Efficient TRAIL-R1/DR4-mediated apoptosis in melanoma cells by tumor necrosis factor-related apoptosis-inducing ligand (TRAIL).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-4658.2010.07590.X

Receptor-selective mutants of apoptosis-inducing ligand 2/tumor necrosis factor-related apoptosis-inducing ligand reveal a greater contribution of death receptor (DR) 5 than DR4 to apoptosis signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-4658.2010.07590.X

Designed tumor necrosis factor-related apoptosis-inducing ligand variants initiating apoptosis exclusively via the DR5 receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-4658.2010.07590.X

Enhancement of antitumor properties of rhTRAIL by affinity increase toward its death receptors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-4658.2010.07590.X

DR4-selective tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) variants obtained by structure-based design

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-4658.2010.07590.X

Phage display-derived peptides as therapeutic alternatives to antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-4658.2010.07590.X

Small peptides as potent mimetics of the protein hormone erythropoietin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-4658.2010.07590.X

Peptide agonist of the thrombopoietin receptor as potent as the natural cytokine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-4658.2010.07590.X

A peptide mimetic of human interferon (IFN)-beta

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-4658.2010.07590.X

Activation of the proapoptotic death receptor DR5 by oligomeric peptide and antibody agonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-4658.2010.07590.X

High affinity type I interleukin 1 receptor antagonists discovered by screening recombinant peptide libraries

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-4658.2010.07590.X

Identification of a peptide blocking vascular endothelial growth factor (VEGF)-mediated angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-4658.2010.07590.X

A potent dimeric peptide antagonist of interleukin-5 that binds two interleukin-5 receptor alpha chains

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-4658.2010.07590.X

"Peptabody": a new type of high avidity binding protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-4658.2010.07590.X

Comparison of a monomeric and dimeric radiolabeled RGD-peptide for tumor targeting

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-4658.2010.07590.X

Design of Potent Peptide Mimetics of Brain-derived Neurotrophic Factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-4658.2010.07590.X

Synthesis and screening of a random dimeric peptide library using the one-bead-one-dimer combinatorial approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-4658.2010.07590.X

Neuronal damage in autoimmune neuroinflammation mediated by the death ligand TRAIL.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-4658.2010.07590.X

Stabilization of TRAIL, an all-beta-sheet multimeric protein, using computational redesign.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-4658.2010.07590.X

Synthetic peptides corresponding to ligand-binding region of death receptors, DR5, Fas, and TNFR, specifically inhibit cell death mediated by the death ligands, respectively

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1742-4658.2010.07590.X

10.1111/J.1742-4658.2010.07590.X

21 January 2018

Identifiers

DOI

1 reference

27 July 2017

1 reference